Issue 34, 2022

Heat-based transdermal delivery of a ramipril loaded cream for treating hypertension

Abstract

Angiotensin-converting enzyme (ACE) inhibitors play an important role in the development of anti-hypertension approaches, with ramipril being one of the most widely used ACE inhibitor prodrugs orally administered once or twice a day. Due to its low bioavailability, large amounts have to be administered to obtain a therapeutic effect. In this work, we propose a ramipril loaded pharmaceutical formulation in contact with an electrothermal actuator based on a gold nanohole array as an efficient approach to increase the transdermal ramipril flux. Using rats as an in vivo model, the effect on the systolic and diastolic blood pressure is evaluated, showing that under optimized conditions the blood pressure could be regulated. Heat activation resulted in total drug delivery out of a bandage loaded with 1 mg ramipril, revealing a flux of 50.9 ± 2.8 μg cm−2 h−1. Importantly, heat-based transdermal dispensing allowed efficient and rapid delivery of ramipril in spontaneously hypertensive rats, with its active form (ramiprilat) detected in blood as early as 5 minutes after delivery onset, accompanied by significant decrease in blood pressure.

Graphical abstract: Heat-based transdermal delivery of a ramipril loaded cream for treating hypertension

Supplementary files

Article information

Article type
Paper
Submitted
26 Apr 2022
Accepted
13 Aug 2022
First published
15 Aug 2022
This article is Open Access
Creative Commons BY-NC license

Nanoscale, 2022,14, 12247-12256

Heat-based transdermal delivery of a ramipril loaded cream for treating hypertension

A. Voronova, Q. Pagneux, R. Decoin, E. Woitrain, L. Butruille, A. Barras, C. Foulon, M. Lecoeur, D. Jaramillo, J. Rumipamba, S. Melinte, A. Abderrahmani, D. Montaigne, R. Boukherroub and S. Szunerits, Nanoscale, 2022, 14, 12247 DOI: 10.1039/D2NR02295H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements